Product Information
AMINOCAPROIC ACID 0.25 GRAM/ML is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.5736 per ML under NDC 00054110058. Its NADAC has been published 86 times since Feb 12, 2025.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AA.
Strength
.25 g/mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054110058
Classification
Generic
Dosage Form
SYRUP
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMINOCAPROIC ACIDApproval Type
Authorized Generic (NDA)
FDA Application
NDA015230FDA Approved
Before 1982
TE Code
AA
On Market Since
3/12/2019
Pharmacological Classes
Price Statistics
The NADAC for AMINOCAPROIC ACID 0.25 GRAM/ML has been published 86 times since Feb 12, 2025, and over the history we have for it it has declined 50.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5736 per ML |
|---|---|
| All-time high | $1.1477 (Feb 12, 2025) |
| All-time low | $0.5736 (Sep 23, 2026) |
| 52-week high | $1.0256 |
| 52-week low | $0.5736 |
| Median price | $0.8425 |
| Average price | $0.8663 |
| Largest weekly change | -11.2% (Jul 22, 2026) |
| Weeks tracked | 86 |
| Tracking since | Feb 12, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Aminocaproic Acid market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Aminocaproic Acid market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antifibrinolytic Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AMINOCAPROIC ACID 0.25 GRAM/ML?
The current National Average Drug Acquisition Cost (NADAC) for AMINOCAPROIC ACID 0.25 GRAM/ML, manufactured by Hikma Pharmaceuticals USA Inc., is $0.5736 per ML (NDC 00054110058), effective Sep 30, 2026.
How has the price of AMINOCAPROIC ACID 0.25 GRAM/ML changed over time?
Over the history we have for it, the NADAC for AMINOCAPROIC ACID 0.25 GRAM/ML has declined 50.0%. It has been tracked across 86 weekly CMS publications since Feb 12, 2025.
What are the highest and lowest recorded NADAC prices for AMINOCAPROIC ACID 0.25 GRAM/ML?
Since Feb 12, 2025, the NADAC for AMINOCAPROIC ACID 0.25 GRAM/ML has ranged from a low of $0.5736 (Sep 23, 2026) to a high of $1.1477 (Feb 12, 2025), with a median of $0.8425 per ML.
Are there cheaper alternatives to AMINOCAPROIC ACID 0.25 GRAM/ML?
No other NADAC-published product currently shares the active ingredient and strength of AMINOCAPROIC ACID 0.25 GRAM/ML in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures AMINOCAPROIC ACID 0.25 GRAM/ML?
AMINOCAPROIC ACID 0.25 GRAM/ML (NDC 00054110058) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.